Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$26,000.00

Bacteriophage lambda replication and phage display

EF 2014-15

Résumé
Our research program involves fundamental studies on bacteriophage lambda virus replication, and genetic engineering attempts to develop a platform for making multiplication-defective lambda virus particles displaying gene fusions. These viral particles can have utility as vaccines and for gene therapy. The platform accomplishes the divergent tasks of enabling very high concentration production of the viral particles, yet effectively killing the virus by introducing genetic modifications that prevent it from multiplying in animal cells or in the environment. The platform will simultaneously produce encapsulated viral DNA and gene-fusion display particles. The gene-fusions displayed on the viral particles enable them to recognize target proteins on specific animal cells, enhancing recognition and viral uptake. Once in the cell, the gene expression cassette that was inserted into the viral genome will encode for the synthesis of a protein(s) that can induce a vaccine response, or support gene therapy. Dr. Hayes has successfully designed gene fusion phage display vaccines to PorcinePCV2 and Bovine BVDV2 viruses, to Ebola and Marburg viruses, and several to anthrax. Advantages of symbiotic research goals: Many of the platform technology gene expression vectors have proven of immense value to our gene expression and viral replication studies. Here, we try to understand how replication initiation from the lambda virus is silenced, which we found involves the participation of a micro RNA. We have identified lambda mutations that escape silencing (Sip) and seek to characterize their effect. Studies also focus on the activities of the lambda replication initiation genes O and P, and host cell proteins. Our particular focus is the interaction between the host DnaB helicase required to unwind DNA during replication and P, which is very toxic to the cell, and appears to stimulate a very high frequency of chromosomal mutation. Lambda escapes the effects of P. We seek to characterize the effects of P on host cell metabolism, and the regulation of gene P expression and P activity in cell.
Programme
Discovery Grants Program - Individual
Emplacement
Saskatchewan, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
138296-2012
Name nom
Hayes, Sidney
Department département
Microbiology and Immunology
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2012
Award amount
26000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
5002
Research subject group en
Genetics
Research subject group fr
Génétique
Research subject en
Molecular genetics
Research subject fr
Génétique moléculaire
Partie
3
Nb partie
5
Application title
Bacteriophage lambda replication and phage display
Keyword
NSERC
Application summary
Our research program involves fundamental studies on bacteriophage lambda virus replication, and genetic engineering attempts to develop a platform for making multiplication-defective lambda virus particles displaying gene fusions. These viral particles can have utility as vaccines and for gene therapy. The platform accomplishes the divergent tasks of enabling very high concentration production of the viral particles, yet effectively killing the virus by introducing genetic modifications that prevent it from multiplying in animal cells or in the environment. The platform will simultaneously produce encapsulated viral DNA and gene-fusion display particles. The gene-fusions displayed on the viral particles enable them to recognize target proteins on specific animal cells, enhancing recognition and viral uptake. Once in the cell, the gene expression cassette that was inserted into the viral genome will encode for the synthesis of a protein(s) that can induce a vaccine response, or support gene therapy. Dr. Hayes has successfully designed gene fusion phage display vaccines to PorcinePCV2 and Bovine BVDV2 viruses, to Ebola and Marburg viruses, and several to anthrax. Advantages of symbiotic research goals: Many of the platform technology gene expression vectors have proven of immense value to our gene expression and viral replication studies. Here, we try to understand how replication initiation from the lambda virus is silenced, which we found involves the participation of a micro RNA. We have identified lambda mutations that escape silencing (Sip) and seek to characterize their effect. Studies also focus on the activities of the lambda replication initiation genes O and P, and host cell proteins. Our particular focus is the interaction between the host DnaB helicase required to unwind DNA during replication and P, which is very toxic to the cell, and appears to stimulate a very high frequency of chromosomal mutation. Lambda escapes the effects of P. We seek to characterize the effects of P on host cell metabolism, and the regulation of gene P expression and P activity in cell.